NasdaqGM - Delayed Quote • USD
RadNet, Inc. (RDNT)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 4:02 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | 0 | 0.18 | 0.55 | 0.76 |
| Low Estimate | -0.13 | 0.11 | 0.24 | 0.36 |
| High Estimate | 0.21 | 0.26 | 0.82 | 1.23 |
| Year Ago EPS | -0.08 | 0.24 | 0.52 | 0.55 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | 421.72M | 437.94M | 1.76B | 1.89B |
| Low Estimate | 415.5M | 434.16M | 1.74B | 1.86B |
| High Estimate | 428.5M | 446M | 1.78B | 1.92B |
| Year Ago Sales | 390.56M | 390.72M | 1.62B | 1.76B |
| Sales Growth (year/est) | 8.00% | 12.10% | 8.60% | 7.90% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.07 | 0.09 | 0.06 | 0.15 |
| EPS Actual | -0.08 | 0.24 | 0.14 | 0.2 |
| Difference | -0.01 | 0.15 | 0.08 | 0.05 |
| Surprise % | -14.30% | 166.70% | 133.30% | 33.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0.18 | 0.55 | 0.76 |
| 7 Days Ago | 0 | 0.18 | 0.55 | 0.76 |
| 30 Days Ago | 0.03 | 0.18 | 0.61 | 0.74 |
| 60 Days Ago | -0.08 | 0.14 | 0.58 | 0.52 |
| 90 Days Ago | -0.08 | 0.14 | 0.57 | 0.5 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | 1 | 2 | 3 | 3 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | RDNT | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 100.00% | -- | -- | 1.50% |
| Next Qtr. | -25.00% | -- | -- | 11.40% |
| Current Year | 5.80% | -- | -- | 5.20% |
| Next Year | 38.20% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 15.00% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 2.49% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Truist Securities: Buy to Buy | 3/28/2024 |
| Maintains | Jefferies: Buy to Buy | 3/22/2024 |
| Initiated | Barclays: Equal-Weight | 3/6/2024 |
| Reiterates | Truist Securities: Buy to Buy | 3/4/2024 |
| Maintains | Truist Securities: Buy to Buy | 12/8/2023 |
| Initiated | Truist Securities: Buy | 8/31/2023 |
Related Tickers
MYGN Myriad Genetics, Inc.
18.63
+0.16%
NTRA Natera, Inc.
91.50
+0.51%
IDXX IDEXX Laboratories, Inc.
494.26
+0.09%
ICLR ICON Public Limited Company
309.44
+0.98%
RVTY Revvity, Inc.
102.68
-0.79%
SERA Sera Prognostics, Inc.
10.04
+0.80%
MEDP Medpace Holdings, Inc.
397.56
-2.36%
MTD Mettler-Toledo International Inc.
1,235.37
-0.48%
QGEN Qiagen N.V.
41.52
-0.88%
VCYT Veracyte, Inc.
19.90
+0.35%